Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-003330
Filing Date
2025-05-21
Accepted
2025-05-21 16:24:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4654
  Complete submission text file 0001950047-25-003330.txt   6176
Mailing Address C/O DYAX CORP. 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
MIGAUSKY GEORGE V (Reporting) CIK: 0001134365 (see all company filings)

Type: 144

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Subject) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-38906 | Film No.: 25973475
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)